Ascendis Pharma A/S (ASND) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist

126.030
-1.640-1.28%

Close Nov 13 16:00 ET

126.030
0.0000.00%

Post 20:01 ET

7.53BMarket Cap-13838P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A Glimpse of Ascendis Pharma's Earnings Potential
BenzingaNov 13 09:01 ET
European Equities Traded in the US as American Depositary Move Higher in Monday Trading
MT NewswiresNov 11 11:06 ET
Earnings Preview: ASND to Report Financial Results Post-market on November 14
Moomoo NewsNov 8 20:00 ET
Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
GlobeNewswireNov 7 16:01 ET
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
BenzingaNov 5 10:00 ET
A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $167 to $289
Moomoo NewsNov 5 08:00 ET · Ratings

Comments

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Nice curl! On watch for recovery. May swing.

$Ascendis Pharma A/S (ASND.US)$

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data